Literature DB >> 21071612

Dissecting CD56dim human NK cells.

Lorenzo Moretta1.   

Abstract

Entities:  

Year:  2010        PMID: 21071612     DOI: 10.1182/blood-2010-09-303057

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  65 in total

1.  Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.

Authors:  Francesco Marras; Elena Nicco; Federica Bozzano; Antonio Di Biagio; Chiara Dentone; Emanuele Pontali; Silvia Boni; Maurizio Setti; Giancarlo Orofino; Eugenio Mantia; Valentina Bartolacci; Francesca Bisio; Agostino Riva; Roberto Biassoni; Lorenzo Moretta; Andrea De Maria
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

2.  High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer.

Authors:  Cheng Sun; Jing Xu; Qiang Huang; Mei Huang; Hao Wen; Chuanshan Zhang; Jinyu Wang; Jiaxi Song; Meijuan Zheng; Haoyu Sun; Haiming Wei; Weihua Xiao; Rui Sun; Zhigang Tian
Journal:  Oncoimmunology       Date:  2016-12-07       Impact factor: 8.110

3.  Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection.

Authors:  Vivek Naranbhai; Christina C Chang; Raveshni Durgiah; Saleha Omarjee; Andrew Lim; Mahomed-Yunus S Moosa; Julian H Elliot; Thumbi Ndung'u; Sharon R Lewin; Martyn A French; William H Carr
Journal:  AIDS       Date:  2014-03-13       Impact factor: 4.177

4.  IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities.

Authors:  Sigrid Dubois; Kevin C Conlon; Jürgen R Müller; Jennifer Hsu-Albert; Nancy Beltran; Bonita R Bryant; Thomas A Waldmann
Journal:  Cancer Immunol Res       Date:  2017-08-25       Impact factor: 11.151

5.  Comparative analysis of the tumor immune-microenvironment of primary and brain metastases of non-small-cell lung cancer reveals organ-specific and EGFR mutation-dependent unique immune landscape.

Authors:  Yoon Kyung Jeon; Doo Hyun Chung; Seung Geun Song; Sehui Kim; Jaemoon Koh; Jeemin Yim; Bogyeong Han; Young A Kim
Journal:  Cancer Immunol Immunother       Date:  2021-01-09       Impact factor: 6.968

6.  Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules.

Authors:  Chiara Barberi; Claudia De Pasquale; Alessandro Allegra; Giacomo Sidoti Migliore; Daniela Oliveri; Fabrizio Loiacono; Vanessa Innao; Caterina Musolino; Daniela Pende; Claudia Cantoni; Paolo Carrega; Maria Cristina Mingari; Stefania Campana; Guido Ferlazzo
Journal:  Blood Adv       Date:  2020-05-26

7.  Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.

Authors:  B E Verstrepen; I G Nieuwenhuis; P Mooij; W M Bogers; A Boonstra; G Koopman
Journal:  Clin Exp Immunol       Date:  2016-04-27       Impact factor: 4.330

8.  Proteome analysis of distinct developmental stages of human natural killer (NK) cells.

Authors:  Maxi Scheiter; Ulrike Lau; Marco van Ham; Björn Bulitta; Lothar Gröbe; Henk Garritsen; Frank Klawonn; Sebastian König; Lothar Jänsch
Journal:  Mol Cell Proteomics       Date:  2013-01-13       Impact factor: 5.911

9.  Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα.

Authors:  Elisavet Serti; Heiyoung Park; Meghan Keane; Ashley C O'Keefe; Elenita Rivera; T Jake Liang; Marc Ghany; Barbara Rehermann
Journal:  Gut       Date:  2016-01-04       Impact factor: 23.059

10.  Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation.

Authors:  Martin Felices; Dave E M Ankarlo; Todd R Lenvik; Heather H Nelson; Bruce R Blazar; Michael R Verneris; Jeffrey S Miller
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.